3 results
Approved WMORecruiting
To determine the influence of esomeprazole on the AUC of regorafenib in patients with mCRC or GIST.
Approved WMORecruiting
To assess benefits and harms of goal directed fluid removal with furosemide versus placebo on patient-important outcome measures in adult ICU patients with fluid overload.
Approved WMORecruiting
Primary ObjectiveTo assess the efficacy of Kamada-AAT for Inhalation administered at a dose of 80 mg daily versus (vs) placebo, with efficacy measured by FEV1 post bronchodilator change from baseline at 104 weeks.Secondary ObjectiveTo assess the…